Primary Objective: Using task fMRI to assess differences in the brain activation during evaluative social feedback and script-driven emotional imagination between participants with BPD and healthy controls. Moment-to-moment self-esteem and mood…
ID
Source
Brief title
Condition
- Personality disorders and disturbances in behaviour
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Behavioural measures: self-report ratings on state self-esteem and mood states
during the tasks (evaluative social feedback and script-driven emotional
imagination. Imaging): Blood-Oxygen-Level Dependent (BOLD) response during
these tasks; BOLD response during rest and after the evaluative social feedback
task (functional connectivity).
Secondary outcome
None
Background summary
Oversensitivity to social signals of potential rejection, fragile self-esteem,
and durable preoccupations about the negative self-images are the clinical
characteristics of borderline personality disorder (BPD). Yet, few studies have
been conducted to clarify the potential socio-cognitive mechanisms and neural
underpinnings associated with this *fragile self*. The goal of this study is to
examine two mechanisms which may contribute to the dysregulation of state
self-esteem provoked by interpersonal acceptance/rejection in borderline
pathology. Our first hypothesis is that the feelings and perception of oneself
in individuals with BPD may be more vulnerable to social feedback. This may be
related to an enhanced self-referential processing during negative social
feedback. Second, we hypothesize that, once the negative self-referential
thought is activated, individuals with BPD may have difficulties to
deliberately regulate these negative thoughts by shifting to mood-incongruent
cognitions, such as engaging into positive self-imaginations.
Study objective
Primary Objective: Using task fMRI to assess differences in the brain
activation during evaluative social feedback and script-driven emotional
imagination between participants with BPD and healthy controls.
Moment-to-moment self-esteem and mood states will be assessed to investigate
whether a decline in the moment-to-moment and global state self-esteem is
directly associated with changes in brain activation patterns in BPD patients
in brain regions associated with social rejection (bilateral anterior insula
and dorsal ACC) and with self-referential thoughts (mPFC).
Secondary objective: Using resting-state fMRI to assess brain functional
connectivity networks. In particular, we focus upon the changes in functional
connectivity networks between baseline and after evaluative social feedback,
which will be compared between the two groups.
Study design
A case-control design (patients with BPD versus healthy controls).
Study burden and risks
Participants will have to lie inside an MRI scanner, which may be of some
discomfort because of the loud scanner noise and being asked to move as little
as possible. Negative evaluative feedback may lower the state self-esteem after
the task, though neutral, negative, and positive feedback will be given
equally. However, the reduced self-esteem will be temporary and within the
tolerable range as more than 100 studies have applied this method to examine
the effect of social feedback. Moreover, a mood boost task by promoting
positive imagination is added to counteract the potential negative mood states.
Wassenaarseweg 52
Leiden 2333 AK
NL
Wassenaarseweg 52
Leiden 2333 AK
NL
Listed location countries
Age
Inclusion criteria
Participants with BPD
1) All BPD participants in this study will be recruited from the participants in the BPD treatment study (P12.227). The diagnosis of BPD will be confirmed by a structured diagnostic interview already assessed in that study. The same inclusion criteria will be adopted, except for additional fMRI requirements (see the protocol for details).
2) After being fully informed about the study and the risks of participation informed consent should be signed.;Healthy participants
1) Participants are able to understand the given information
2) After being fully informed about the study and the risks of participation informed consent should be signed
3) Participants are in excellent mental and physical condition
4) Age: > 18 yrs, < 55, and matched with BPD patients
Exclusion criteria
Participants with BPD
1) Alcohol or drugs abuse
2) The use of benzodiazepines more than the equivalent of 20 mg of oxazepam or any antipsychotic medication (Stable use of SSRI*s is allowed)
3) Metal implants, surgical clips, pacemakers, and left-handedness.;Healthy participants
1) History of psychiatric problems by the MINI
2) Somatic illnesses
3) Alcohol or drug dependence by the MINI
4) Regular medications
5) Metal implants, surgical clips, pacemakers, and left-handedness
Design
Recruitment
metc-ldd@lumc.nl
metc-ldd@lumc.nl
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL42510.058.12 |